Jun‐ichi Eiki

1.6k total citations
28 papers, 1.3k citations indexed

About

Jun‐ichi Eiki is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jun‐ichi Eiki has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 16 papers in Molecular Biology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jun‐ichi Eiki's work include Pancreatic function and diabetes (23 papers), Metabolism, Diabetes, and Cancer (12 papers) and Diabetes Treatment and Management (9 papers). Jun‐ichi Eiki is often cited by papers focused on Pancreatic function and diabetes (23 papers), Metabolism, Diabetes, and Cancer (12 papers) and Diabetes Treatment and Management (9 papers). Jun‐ichi Eiki collaborates with scholars based in Japan and United States. Jun‐ichi Eiki's co-authors include T. Nishimura, Yasufumi Nagata, Kenji Kamata, Morihiro Mitsuya, Bei B. Zhang, Barry E. Levin, Ambrose A. Dunn-Meynell, Sumika Ohyama, Hideka Hosaka and Kaori Sasaki and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Diabetes.

In The Last Decade

Jun‐ichi Eiki

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jun‐ichi Eiki Japan	17	822	791	423	230	227	28	1.3k
Faika Mseeh United States	14	385 0.5×	623 0.8×	546 1.3×	88 0.4×	72 0.3×	19	1.1k
Claus T. Christoffersen Denmark	20	143 0.2×	884 1.1×	367 0.9×	429 1.9×	366 1.6×	47	1.8k
Kristine Griffett United States	15	243 0.3×	417 0.5×	122 0.3×	122 0.5×	122 0.5×	25	926
Kim Masuda United States	15	229 0.3×	621 0.8×	153 0.4×	35 0.2×	121 0.5×	17	1.4k
Bridget Butler United States	15	143 0.2×	279 0.4×	536 1.3×	477 2.1×	270 1.2×	30	1.1k
Jill M. McFadden United States	13	222 0.3×	790 1.0×	73 0.2×	166 0.7×	213 0.9×	17	1.3k
Nicholas D. Holliday United Kingdom	21	167 0.2×	925 1.2×	137 0.3×	377 1.6×	220 1.0×	56	1.5k
Manuel Grundmann Germany	19	320 0.4×	826 1.0×	309 0.7×	29 0.1×	148 0.7×	33	1.2k
Diane M. Hargrove United States	17	169 0.2×	346 0.4×	223 0.5×	50 0.2×	157 0.7×	29	792
Nieves Rodríguez‐Henche Spain	19	180 0.2×	497 0.6×	122 0.3×	80 0.3×	71 0.3×	31	1.1k

Countries citing papers authored by Jun‐ichi Eiki

Since Specialization

Citations

This map shows the geographic impact of Jun‐ichi Eiki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐ichi Eiki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐ichi Eiki more than expected).

Fields of papers citing papers by Jun‐ichi Eiki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun‐ichi Eiki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐ichi Eiki. The network helps show where Jun‐ichi Eiki may publish in the future.

Co-authorship network of co-authors of Jun‐ichi Eiki

This figure shows the co-authorship network connecting the top 25 collaborators of Jun‐ichi Eiki. A scholar is included among the top collaborators of Jun‐ichi Eiki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun‐ichi Eiki. Jun‐ichi Eiki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ohsugi, Mitsuru, et al.. (2021). Comorbidities and complications in Japanese patients with type 2 diabetes mellitus: Retrospective analyses of J-DREAMS, an advanced electronic medical records database. Diabetes Research and Clinical Practice. 178. 108845–108845. 24 indexed citations

Suzuki, Ryo, Jun‐ichi Eiki, Takashi Moritoyo, et al.. (2018). Effect of short‐term treatment with sitagliptin or glibenclamide on daily glucose fluctuation in drug‐naïve Japanese patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 20(9). 2274–2281. 11 indexed citations

Hasegawa, Takuro, Jun‐ichi Eiki, & Masato Chiba. (2014). Interindividual Variations in Metabolism and Pharmacokinetics of 3-(6-Methylpyridine-3-yl-sulfanyl)-6-(4H-[1,2,4]triazole-3-yl-sulfanyl)-N-(1,3-thiazole-2-yl)-2-pyridine carboxamide, a Glucokinase Activator, in Rats Caused by the Genetic Polymorphism of CYP2D1. Drug Metabolism and Disposition. 42(9). 1548–1555. 4 indexed citations

Futamura, Mayumi, Jun Yao, Raynald Bergeron, et al.. (2012). Chronic treatment with a glucokinase activator delays the onset of hyperglycaemia and preserves beta cell mass in the Zucker diabetic fatty rat. Diabetologia. 55(4). 1071–1080. 33 indexed citations

Eiki, Jun‐ichi, Yasufumi Nagata, Mayumi Futamura, et al.. (2011). Pharmacokinetic and Pharmacodynamic Properties of the Glucokinase Activator MK-0941 in Rodent Models of Type 2 Diabetes and Healthy Dogs. Molecular Pharmacology. 80(6). 1156–1165. 25 indexed citations

Nakamura, Akinobu, et al.. (2011). Effect of long-term treatment with a small-molecule glucokinase activator on glucose metabolism, lipid profiles and hepatic function. Journal of Diabetes Investigation. 2(4). 276–279. 13 indexed citations

Eiki, Jun‐ichi & Toshihiko Yada. (2011). Dynamics of plasma active GLP-1 versus insulin and glucose concentrations during GLP-1 infusion in rat model of postprandial hyperglycemia. Endocrine Journal. 58(8). 691–698. 4 indexed citations

Ohyama, Sumika, Hiroki Takano, Tomoharu Iino, et al.. (2010). A small-molecule glucokinase activator lowers blood glucose in the sulfonylurea-desensitized rat. European Journal of Pharmacology. 640(1-3). 250–256. 18 indexed citations

Dunn-Meynell, Ambrose A., Nicole M. Sanders, Douglas S. Compton, et al.. (2009). Relationship among Brain and Blood Glucose Levels and Spontaneous and Glucoprivic Feeding. Journal of Neuroscience. 29(21). 7015–7022. 113 indexed citations

10.

Ishikawa, Makoto, Katsumasa Nonoshita, Yoshio Ogino, et al.. (2009). Discovery of novel 2-(pyridine-2-yl)-1H-benzimidazole derivatives as potent glucokinase activators. Bioorganic & Medicinal Chemistry Letters. 19(15). 4450–4454. 46 indexed citations

11.

Eiki, Jun‐ichi, Norihiro Nagano, Tomoharu Iino, et al.. (2009). A selective small molecule glucagon-like peptide-1 secretagogue acting via depolarization-coupled Ca2+ influx. Journal of Endocrinology. 201(3). 361–367. 16 indexed citations

12.

Iino, Tomoharu, Kenji Kamata, Kaori Sasaki, et al.. (2009). Discovery of potent and orally active 3-alkoxy-5-phenoxy-N-thiazolyl benzamides as novel allosteric glucokinase activators. Bioorganic & Medicinal Chemistry. 17(7). 2733–2743. 55 indexed citations

13.

Iino, Tomoharu, Yasuhiro Sasaki, Morihiro Mitsuya, et al.. (2009). Discovery and structure–activity relationships of a novel class of quinazoline glucokinase activators. Bioorganic & Medicinal Chemistry Letters. 19(19). 5531–5538. 33 indexed citations

14.

Takahashi, Keiji, Noriaki Hashimoto, Kenji Kamata, et al.. (2009). The design and optimization of a series of 2-(pyridin-2-yl)-1H-benzimidazole compounds as allosteric glucokinase activators. Bioorganic & Medicinal Chemistry. 17(19). 7042–7051. 30 indexed citations

15.

Iino, Tomoharu, Noriaki Hashimoto, Kaori Sasaki, et al.. (2009). Structure–activity relationships of 3,5-disubstituted benzamides as glucokinase activators with potent in vivo efficacy. Bioorganic & Medicinal Chemistry. 17(11). 3800–3809. 45 indexed citations

16.

Nishimura, T., Tomoharu Iino, Morihiro Mitsuya, et al.. (2009). Identification of novel and potent 2-amino benzamide derivatives as allosteric glucokinase activators. Bioorganic & Medicinal Chemistry Letters. 19(5). 1357–1360. 38 indexed citations

17.

Mitsuya, Morihiro, Kenji Kamata, Hitomi Watanabe, et al.. (2009). Discovery of novel 3,6-disubstituted 2-pyridinecarboxamide derivatives as GK activators. Bioorganic & Medicinal Chemistry Letters. 19(10). 2718–2721. 38 indexed citations

18.

Levin, Barry E., Thomas Becker, Jun‐ichi Eiki, Bei B. Zhang, & Ambrose A. Dunn-Meynell. (2008). Ventromedial Hypothalamic Glucokinase Is an Important Mediator of the Counterregulatory Response to Insulin-Induced Hypoglycemia. Diabetes. 57(5). 1371–1379. 64 indexed citations

19.

Fujimura, M., Takao Nakamura, Sumika Ohyama, et al.. (2007). Metabolic impact of overexpression of liver glycogen synthase with serine-to-alanine substitutions in rat primary hepatocytes. Archives of Biochemistry and Biophysics. 466(2). 283–289. 6 indexed citations

20.

Futamura, Mayumi, Hideka Hosaka, Kaori Sasaki, et al.. (2006). An Allosteric Activator of Glucokinase Impairs the Interaction of Glucokinase and Glucokinase Regulatory Protein and Regulates Glucose Metabolism. Journal of Biological Chemistry. 281(49). 37668–37674. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact